For nearly seven years, the European Union has tried to legislate against endocrine disruptors. Amid intense debate surrounding the impact of these new measures, a number of recent studies have shown that the EU’s trading partners, notably the United States and Canada, significantly influenced the committee’s work on this issue.
In Short